Heart failure fluid battle: which pill works better?

NCT ID NCT07199088

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests two water pills—acetazolamide and metolazone—added to standard diuretics in 320 adults hospitalized with acute decompensated heart failure. The goal is to see which drug clears fluid buildup faster and more safely, reducing hospital stays and complications. Participants receive one of the two pills daily, and doctors track decongestion, kidney function, and side effects.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
acetazolamide and metolazone (diuretic drugs)
What this could lead to
If it works, this could identify a better add-on diuretic to help heart failure patients get rid of excess fluid faster and shorten hospital stays.
What could go wrong
This is a single-center study in Pakistan, so results may not apply to other populations. Both drugs can cause kidney problems or electrolyte imbalances, and the trial is not blinded, which could bias results.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE DECOMPENSATED HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Quaid e Azam Medical College , bahawalpur

    RECRUITING

    Chak Four Hundred Fifty-four, Punjab Province, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.